Vincent Bours

18.0k citations
255 papers · 12.4k · 1 hit paper · h-index 61

Impact in

  • Cancer Research top 0.1%
    • NF-κB Signaling Pathways
  • Immunology top 0.5%
    • Immune Response and Inflammation
    • interferon and immune responses
    • Immune Cell Function and Interaction

Papers in

  • Molecular Biology 88
    • Natural product bioactivities and synthesis 11
  • Cancer Research 80
    • NF-κB Signaling Pathways 57
    • Cancer-related molecular mechanisms research 11
    • MicroRNA in disease regulation 11
Co-authors
Marie‐Paule Merville (49 shared papers)Alain Chariot (24 shared papers)Patrick Viatour (7 shared papers)Ulrich Siebenlist (16 shared papers)Mohamed Bentires‐Alj (16 shared papers)Giuseppina Bonizzi (9 shared papers)Pierre A. Robe (23 shared papers)Jacques Gielen (19 shared papers)
Journals
Biochemical Pharmacology (12 papers)Oncogene (11 papers)Molecular and Cellular Biology (9 papers)Journal of Biological Chemistry (7 papers)BMC Cancer (6 papers)
Partner nations
BelgiumUnited StatesFrance

In The Last Decade

Vincent Bours

252 papers receiving 12.1k citations

Vincent Bours's Hit Papers

Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation 2004 · 1.3k citations
1.3k0+7+14Years since publication4008001.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2004 Trends in Biochemical Sciences

Peers

Vincent Bours
Comparison fields: 5 of 151
  • Cancer Research 4.2k
  • Immunology 3.4k
  • Oncology 2.0k
  • Molecular Biology 5.4k
  • Genetics 765
Replace Jeremy Saklatvala with:
Jeremy Saklatvala United Kingdom
Robert Newton United States
Fionula M. Brennan United Kingdom
Richard D. Ye United States
Ferdinando Nicoletti Italy
Francesco Colotta Italy
Thomas A. Hamilton United States
Richard J. Ulevitch United States
Matthias Gaestel Germany
Marta Muzio Italy
Vincent Bours relative to Jeremy Saklatvala United Kingdom Jeremy Saklatvala's profile →
Citations per field
00.5×2×2.9×
Jeremy Saklatvala · 1×
Citations per year

Countries citing papers authored by Vincent Bours

Since Specialization
Citations

This map shows the geographic impact of Vincent Bours's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Bours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Bours more than expected).

Fields of papers citing papers by Vincent Bours

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Bours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Bours. The network helps show where Vincent Bours may publish in the future.

Co-authors

The 25 scholars most cited alongside Vincent Bours, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Bours Line = papers co-authored together Vincent Bours links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Trends in Biochemical Sciences ·Patrick Viatour, Marie‐Paule Merville, Vincent Bours, Alain Chariot
Hit paper breakdown →		20041287
2
The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers
Cell ·Vincent Bours
1993452
3
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
Oncogene ·Mohamed Bentires‐Alj, Véronique Barbu, Marianne Fillet, Alain Chariot, Biserka Relić, Nathalie Jacobs, Jacques Gielen, Marie‐Paule Merville, Vincent Bours
2003392
4
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
Molecular and Cellular Biology ·Rolf-Peter Ryseck, Paulina Bull, Mónica Takamiya, Vincent Bours, Ulrich Siebenlist, Paweł Dobrzański, R Bravo
1992329
5
Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs
Nature ·Vincent Bours, Juanita Villalobos, Parris R. Burd, Kathleen Kelly, Ulrich Siebenlist
1990306
6
The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition
Nature ·Guido Franzoso, Vincent Bours, Sun Park, Michiyo Tomfta-Yamaguchi, Kathleen Kelly, Ulrich Siebenlist
1992290
7
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
Molecular and Cellular Biology ·Vincent Bours, Parris R. Burd, Keith Brown, Juanita Villalobos, S. Park, Rolf-Peter Ryseck, R Bravo, Kathleen Kelly, Ulrich Siebenlist
1992260
8
Reactive Oxygen Intermediate-Dependent NF-κB Activation by Interleukin-1β Requires 5-Lipoxygenase or NADPH Oxidase Activity
Molecular and Cellular Biology ·Giuseppina Bonizzi, Jacques Piette, Sonia Schoonbroodt, Roland Greimers, Laurence Havard, Marie-Paule Merville, Vincent Bours
1999207
9
Multiple redox regulation in NF-kappaB transcription factor activation.
PubMed ·Jacques Piette, Bernard Piret, Guiseppina Bonizzi, Sonia Schoonbroodt, Marie Paule Merville, Sylvie Legrand-Poels, Vincent Bours
1997195
10
Nuclear factor-κB, cancer, and apoptosis
Biochemical Pharmacology ·Vincent Bours, Mohamed Bentires‐Alj, Anne‐Cecile Hellin, Patrick Viatour, Pierre A. Robe, Sylvie Delhalle, Valérie Benoît, Marie‐Paule Merville
2000185
11
Transcription Impairment and Cell Migration Defects in Elongator-Depleted Cells: Implication for Familial Dysautonomia
Molecular Cell ·Pierre Close, Nicola A. Hawkes, Isabelle Cornez, Catherine Creppe, Charles Lambert, Bernard Rogister, Ulrich Siebenlist, Marie‐Paule Merville, Susan A. Slaugenhaupt, Vincent Bours, Jesper Q. Svejstrup, Alain Chariot
2006177
12
The NF-κB transcription factor and cancer: high expression of NF-κB- and IκB-related proteins in tumor cell lines
Biochemical Pharmacology ·Vincent Bours, Emmanuel Dejardin, Francine Goujon-Letawe, Marie‐Paule Merville, Vincent Castronovo
1994168
13
The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
The EMBO Journal ·Guido Franzoso, Vincent Bours, V. Azarenko, S. Park, M Tomita-Yamaguchi, T. Kanno, Keith Brown, Ulrich Siebenlist
1993158
14
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes
Clinical Genetics ·Constantine A. Stratakis, MA Tichomirowa, Sosipatros A. Boikos, MF Azevedo, Maya Lodish, Marco Martari, Santosh Kumar Verma, AF Daly, Margarita Raygada, MF Keil, J. Papademetriou, Limor Drori-Herishanu, Anélia Horvath, K.M. Tsang, Maria Nesterova, Samantha Franklin, J‐F Vanbellinghen, Vincent Bours, Roberto Salvatori, Albert Beckers
2010155
15
An insertion deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases
Human Molecular Genetics ·Vinciane Dideberg, Guðrún Kristjánsdóttir, Lili Milani, Cécile Libioulle, Snævar Sigurðsson, Édouard Louis, A.-C. Wiman, Séverine Vermeire, Paul Rutgeerts, Jacques Bélaïche, Denis Franchimont, A. Van Gossum, Vincent Bours, A-C Syvänen
2007150
16
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer
Oncotarget ·Nicolas Bovy, Benoît Blomme, Pierre Frères, Stella Dederen, Olivier Nivelles, Michelle Lion, Oriane Carnet, Joseph Martial, Agnès Noël, Marc Thiry, Guy Jérusalem, Claire Josse, Vincent Bours, Sébastien P. Tabruyn, Ingrid Struman
2015146
17
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
BMC Cancer ·Pierre A. Robe, Didier Martin, Minh Nguyen-Khac, Maria Artesi, Manuel Deprez, Adelin Albert, Sophie Vanbelle, Stèphane Califice, Markus Bredel, Vincent Bours
2009145
18
NF-κB2/p100 induces Bcl-2 expression
Leukemia ·Patrick Viatour, Mohamed Bentires‐Alj, Alain Chariot, Valérie Deregowski, Laurence de Leval, M. P. Merville, Vincent Bours
2003142
19
A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay
Journal of Clinical Microbiology ·Maria Artesi, Sébastien Bontems, Paul Göbbels, Marc Franckh, Piet Maes, Raphaël Boreux, Cécile Meex, Pierrette Melin, Marie‐Pierre Hayette, Vincent Bours, Keith Durkin
2020141
20
Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by Interleukin-1
Biochemical Pharmacology ·Giuseppina Bonizzi, Jacques Piette, Marie-Paule Merville, Vincent Bours
2000141

About Vincent Bours

Vincent Bours is a scholar working on Molecular Biology, Cancer Research, Immunology, Genetics and Oncology, having authored 255 papers that have together received 12.4k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (57 papers), Immune Response and Inflammation (21 papers), Hemoglobinopathies and Related Disorders (13 papers), Cytokine Signaling Pathways and Interactions (13 papers), Cancer-related molecular mechanisms research (11 papers), Natural product bioactivities and synthesis (11 papers), MicroRNA in disease regulation (11 papers) and Pituitary Gland Disorders and Treatments (10 papers). The work is most often cited by research in Cancer Research (4.2k citations), Immunology (3.4k citations), Oncology (2.0k citations), Molecular Biology (5.4k citations) and Genetics (765 citations). Vincent Bours has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Marie‐Paule Merville, Alain Chariot, Patrick Viatour, Ulrich Siebenlist, Mohamed Bentires‐Alj, Giuseppina Bonizzi, Pierre A. Robe, Jacques Gielen, Kathleen Kelly and Jacques Piette. Their work appears in journals such as Biochemical Pharmacology, Oncogene, Molecular and Cellular Biology, Journal of Biological Chemistry and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeremy SaklatvalaBreakdown of academic impact, for papers by Robert NewtonBreakdown of academic impact, for papers by Fionula M. BrennanBreakdown of academic impact, for papers by Richard D. YeBreakdown of academic impact, for papers by Ferdinando NicolettiBreakdown of academic impact, for papers by Francesco ColottaBreakdown of academic impact, for papers by Thomas A. HamiltonBreakdown of academic impact, for papers by Richard J. UlevitchBreakdown of academic impact, for papers by Matthias GaestelBreakdown of academic impact, for papers by Marta Muzio